DYmista NAsal Spray in CHInese Patients

NCT03599791 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT
DRUG: Azelastine Hydrochloride 0.137 MG/ACTUAT
DRUG: Fluticasone Propionate 0.05 MG/ACTUAT

Sponsor

MEDA Pharma GmbH & Co. KG